SCHEMBL23488592

SCHEMBL23488592

Cc1ccc(OCc2ccccc2)cc1C(=O)OC[C@H]1OC[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.44
MEN1 O00255 1/20 0.43
HSP90AA1 P07900 1/20 0.43
KMT2A Q03164 1/20 0.43
S1PR1 P21453 1/20 0.41
S1PR5 Q9H228 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA5 P30532 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
NMT1 P30419 4/20 0.39
NMT2 O60551 1/20 0.39
FFAR1 O14842 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488636 0.92 MAOB (0.44) MAOBMEN1HSP90AA1KMT2AS1PR1
SCHEMBL23488152 0.84 MAOB (0.44) MAOBMEN1HSP90AA1KMT2AS1PR1
SCHEMBL23488593 0.84 MAOB (0.44) MAOBMEN1HSP90AA1KMT2AS1PR1
SCHEMBL23488472 0.82 MAOB (0.43) MAOBMEN1HSP90AA1KMT2AS1PR1
SCHEMBL23488256 0.80 MAOB (0.41) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL2321431 0.79 KMT2A (0.56) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488499 0.78 MRGPRX4 (0.43) MAOBMEN1KMT2ACHRNB2CHRNA5
SCHEMBL23488502 0.77 ALDH1A1 (0.45) MAOBMEN1KMT2AS1PR1S1PR5
SCHEMBL23488269 0.77 KMT2A (0.42) MAOBMEN1HSP90AA1KMT2ANPC1
SCHEMBL23488622 0.76 MAOB (0.44) MAOBMEN1HSP90AA1KMT2AS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885MEN1 1749/4885HSP90AA1 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.